Koyfin Home > Directory > Health Care > ANI Pharma Inc > EBIT

ANI Pharma Inc EBIT Chart (ANIP)

ANI Pharma Inc annual/quarterly EBIT from 2012 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • ANI Pharma Inc EBIT for the quarter ending June 06, 2020 was $-3m a 343.70% decrease of -10m year over year
  • ANI Pharma Inc EBIT for the last 12 months ending June 06, 2020 was $-8m a 550.52% decrease of -42m year over year
  • ANI Pharma Inc Annual EBIT for 2019 was $16m a -149.35% decrease of -25m from 2018
  • ANI Pharma Inc Annual EBIT for 2018 was $41m a 28.63% increase of 12m from 2017
  • ANI Pharma Inc Annual EBIT for 2017 was $29m a -16.19% decrease of -5m from 2016
Other Income Statement Metrics:
  • ANI Pharma Inc EBITDA for the quarter ending December 12, 2018 was $20m a 26.31% increase of 5m year over year
  • ANI Pharma Inc Net Income for the quarter ending December 12, 2018 was $5m a 58.56% increase of 3m year over year
  • ANI Pharma Inc Total Revenue for the quarter ending December 12, 2018 was $57m a 18.63% increase of 11m year over year
View Chart On Koyfin

Quarterly ANIP EBIT Data

06/2020$-3m
03/2020$-8m
12/2019$-5m
09/2019$7m
06/2019$12m
03/2019$4m
12/2018$11m
09/2018$10m
06/2018$9m
03/2018$7m

Annual ANIP EBIT Data

2019$16m
2018$41m
2017$29m
2016$34m
2015$33m
2014$21m
2013$6m
2012$1m
2011$0m